Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study of VIB7734 for the Treatment of Moderate to Severely Active SLE

ClinicalTrials.gov ID: NCT04925934

Public ClinicalTrials.gov record NCT04925934. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 3:29 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of VIB7734 for the Treatment of Moderate to Severely Active Systemic Lupus Erythematosus

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of VIB7734 for the Treatment of Moderate to Severely Active Systemic Lupus Erythematosus in approximately 195 participants. The study duration will be 48 weeks, with a safety follow-up through week 56.There will be 3 parallel arms - 2 active treatment and 1 placebo.

Study identification

NCT ID
NCT04925934
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Amgen
Industry
Enrollment
214 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 28, 2021 (Actual)
Primary completion
May 16, 2023 (Actual)
Completion
Jun 9, 2023 (Actual)
Last update posted
Jul 23, 2024

2021 – 2023

United States locations

U.S. sites
17
U.S. states
9
U.S. cities
17
Facility City State ZIP Site status
Inland Rheumatology Clinical Trials Incorporated Upland California 91786 —
Clinical Research of West Florida Inc - Clearwater Clearwater Florida 33765-2616 —
Millennium Research Ormond Beach Florida 32174 —
IRIS Research and Development LLC Plantation Florida 33324 —
Clinical Research of West Florida Inc - Tampa Tampa Florida 33606-1246 —
Emory University School of Medicine Atlanta Georgia 30322 —
Bluegrass Community Research Inc Lexington Kentucky 40504-2931 —
NYU Langone Ambulatory Care Brooklyn Heights Brooklyn New York 11201 —
Feinstein Institute For Medical Research Manhasset New York 11030-3816 —
SUNY Upstate Medical Center Syracuse New York 13210 —
DJL Clinical Research Charlotte North Carolina 28210-8509 —
Paramount Medical Research and Consulting LLC Middleburg Heights Ohio 44130-3483 —
Tekton Research Inc Austin Texas 78745-1485 —
Precision Comprehensive Clinical Research Solutions Colleyville Texas 76034-5913 —
Metroplex Clinical Research Center Dallas Texas 75231 —
Southwest Rheumatology Research, LLC Mesquite Texas 75150 —
Spectrum Medical, Inc Danville Virginia 24541-1222 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 50 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04925934, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 23, 2024 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04925934 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →